154 related articles for article (PubMed ID: 21997717)
1. Conversions at C-30 of glycyrrhetinic acid and their impact on antitumor activity.
Csuk R; Schwarz S; Siewert B; Kluge R; Ströhl D
Arch Pharm (Weinheim); 2012 Mar; 345(3):223-30. PubMed ID: 21997717
[TBL] [Abstract][Full Text] [Related]
2. Does one keto group matter? Structure-activity relationships of glycyrrhetinic acid derivatives modified at position C-11.
Csuk R; Schwarz S; Kluge R; Ströhl D
Arch Pharm (Weinheim); 2012 Jan; 345(1):28-32. PubMed ID: 22076975
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity of ring A modified glycyrrhetinic acid derivatives.
Csuk R; Schwarz S; Siewert B; Kluge R; Ströhl D
Eur J Med Chem; 2011 Nov; 46(11):5356-69. PubMed ID: 21959232
[TBL] [Abstract][Full Text] [Related]
4. Improvement of the cytotoxicity and tumor selectivity of glycyrrhetinic acid by derivatization with bifunctional amino acids.
Csuk R; Schwarz S; Kluge R; Ströhl D
Arch Pharm (Weinheim); 2011 Aug; 344(8):505-13. PubMed ID: 21674592
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
Schwarz S; Csuk R
Bioorg Med Chem; 2010 Nov; 18(21):7458-74. PubMed ID: 20932766
[TBL] [Abstract][Full Text] [Related]
6. A "natural" approach: synthesis and cytoxicity of monodesmosidic glycyrrhetinic acid glycosides.
Schwarz S; Siewert B; Xavier NM; Jesus AR; Rauter AP; Csuk R
Eur J Med Chem; 2014 Jan; 72():78-83. PubMed ID: 24361520
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
Csuk R; Schwarz S; Kluge R; Ströhl D
Eur J Med Chem; 2010 Dec; 45(12):5718-23. PubMed ID: 20884085
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel heterocyclic ring-fused 18β-glycyrrhetinic acid derivatives with antitumor and antimetastatic activity.
Gao C; Dai FJ; Cui HW; Peng SH; He Y; Wang X; Yi ZF; Qiu WW
Chem Biol Drug Des; 2014 Aug; 84(2):223-33. PubMed ID: 24612785
[TBL] [Abstract][Full Text] [Related]
9. First Occurrence of a Furano-glycyrrhetinoate and Its Cytotoxicity.
Heller L; Sommerwerk S; Tzschöckell F; Wiemann J; Schwarz S; Siewert B; Al-Harrasi A; Csuk R
Arch Pharm (Weinheim); 2015 Dec; 348(12):889-96. PubMed ID: 26548762
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel spin labeled 18β-glycyrrhetinic acid derivatives.
Liu Y; Qian K; Wang CY; Chen CH; Yang X; Lee KH
Bioorg Med Chem Lett; 2012 Dec; 22(24):7530-3. PubMed ID: 23122524
[TBL] [Abstract][Full Text] [Related]
11. 18β-Glycyrrhetinic acid derivatives induced mitochondrial-mediated apoptosis through reactive oxygen species-mediated p53 activation in NTUB1 cells.
Lin KW; Huang AM; Hour TC; Yang SC; Pu YS; Lin CN
Bioorg Med Chem; 2011 Jul; 19(14):4274-85. PubMed ID: 21696969
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of glycyrrhetinic acid derivatives as antitumor agents.
Zhou F; Wu GR; Cai DS; Xu B; Yan MM; Ma T; Guo WB; Zhang WX; Huang XM; Jia XH; Yang YQ; Gao F; Wang PL; Lei HM
Eur J Med Chem; 2019 Sep; 178():623-635. PubMed ID: 31226654
[TBL] [Abstract][Full Text] [Related]
13. Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28.
Siewert B; Pianowski E; Csuk R
Eur J Med Chem; 2013; 70():259-72. PubMed ID: 24161703
[TBL] [Abstract][Full Text] [Related]
14. 18beta-Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity.
Lee CS; Kim YJ; Lee MS; Han ES; Lee SJ
Life Sci; 2008 Sep; 83(13-14):481-9. PubMed ID: 18721818
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of novel (E) stilbene-based antitumor agents.
Csuk R; Albert S; Siewert B; Schwarz S
Eur J Med Chem; 2012 Aug; 54():669-78. PubMed ID: 22749392
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of antitumor-active arglabin derivatives.
Csuk R; Heinold A; Siewert B; Schwarz S; Barthel A; Kluge R; Ströhl D
Arch Pharm (Weinheim); 2012 Mar; 345(3):215-22. PubMed ID: 21997763
[TBL] [Abstract][Full Text] [Related]
17. N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
Lallemand B; Chaix F; Bury M; Bruyère C; Ghostin J; Becker JP; Delporte C; Gelbcke M; Mathieu V; Dubois J; Prévost M; Jabin I; Kiss R
J Med Chem; 2011 Oct; 54(19):6501-13. PubMed ID: 21888390
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of furoxan-based nitric oxide-releasing derivatives of glycyrrhetinic acid as anti-hepatocellular carcinoma agents.
Lai Y; Shen L; Zhang Z; Liu W; Zhang Y; Ji H; Tian J
Bioorg Med Chem Lett; 2010 Nov; 20(22):6416-20. PubMed ID: 20932754
[TBL] [Abstract][Full Text] [Related]
19. 18β-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines.
Lee CS; Yang JC; Kim YJ; Jang ER; Kim W; Myung SC
Eur J Pharmacol; 2010 Dec; 649(1-3):354-61. PubMed ID: 20868669
[TBL] [Abstract][Full Text] [Related]
20. [Research progress of anticancer mechanism of glycyrrhetinic acid].
Gao Z; Kang X; Xu C
Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(22):3213-6. PubMed ID: 22375411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
